Definitive Healthcare Corp Stock Performance
| DH Stock | USD 3.84 0.18 4.48% |
On a scale of 0 to 100, Definitive Healthcare holds a performance score of 12. The firm shows a Beta (market volatility) of 0.99, which means possible diversification benefits within a given portfolio. Definitive Healthcare returns are very sensitive to returns on the market. As the market goes up or down, Definitive Healthcare is expected to follow. Please check Definitive Healthcare's maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Definitive Healthcare's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Definitive Healthcare Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Definitive Healthcare demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.48) | Five Day Return (1.03) | Year To Date Return (6.80) | Ten Year Return (91.13) | All Time Return (91.13) |
1 | Acquisition by Shamsuddin Kate Marie of 243446 shares of Definitive Healthcare subject to Rule 16b-3 | 04/28/2025 |
2 | Disposition of 7873 shares by Richard Booth of Definitive Healthcare at 2.75 subject to Rule 16b-3 | 05/01/2025 |
3 | Definitive Healthcare Corp Q1 2025 Earnings Report Preview What To Expect | 05/07/2025 |
4 | The Goldman Sachs Group Raises Definitive Healthcare Price Target to 3.40 | 05/15/2025 |
5 | Proactive Strategies - news.stocktradersdaily.com | 05/29/2025 |
6 | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635 | 06/03/2025 |
7 | Acquisition by Hamood Samuel A of 55911 shares of Definitive Healthcare subject to Rule 16b-3 | 06/05/2025 |
8 | Acquisition by Casey Heller of 485881 shares of Definitive Healthcare subject to Rule 16b-3 | 06/10/2025 |
9 | Disposition of 22615 shares by Jason Krantz of Definitive Healthcare at 4.41 subject to Rule 16b-3 | 06/12/2025 |
10 | Insider Trading | 06/16/2025 |
11 | Disposition of 1012 shares by Shamsuddin Kate Marie of Definitive Healthcare at 3.65 subject to Rule 16b-3 | 06/17/2025 |
12 | Disposition of 27080 shares by Richard Booth of Definitive Healthcare at 4.86 subject to Rule 16b-3 | 07/10/2025 |
13 | What drives Definitive Healthcare Corp. stock price - Free Stock Index Interpretation - Jammu Links News | 07/18/2025 |
| Begin Period Cash Flow | 131 M | |
| Free Cash Flow | 45.9 M |
Definitive | Build AI portfolio with Definitive Stock |
Definitive Healthcare Relative Risk vs. Return Landscape
If you would invest 251.00 in Definitive Healthcare Corp on April 20, 2025 and sell it today you would earn a total of 133.00 from holding Definitive Healthcare Corp or generate 52.99% return on investment over 90 days. Definitive Healthcare Corp is generating 0.791% of daily returns and assumes 4.8507% volatility on return distribution over the 90 days horizon. Put differently, 43% of stocks are less risky than Definitive on the basis of their historical return distribution, and some 85% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Definitive Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Definitive Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Definitive Healthcare Corp, and traders can use it to determine the average amount a Definitive Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1631
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.85 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Definitive Healthcare is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Definitive Healthcare by adding it to a well-diversified portfolio.
Definitive Healthcare Fundamentals Growth
Definitive Stock prices reflect investors' perceptions of the future prospects and financial health of Definitive Healthcare, and Definitive Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Definitive Stock performance.
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.0043 | ||||
| Profit Margin | (2.06) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 411.45 M | ||||
| Shares Outstanding | 107.34 M | ||||
| Price To Book | 1.34 X | ||||
| Price To Sales | 1.74 X | ||||
| Revenue | 252.2 M | ||||
| Gross Profit | 206.82 M | ||||
| EBITDA | (567.24 M) | ||||
| Net Income | (591.45 M) | ||||
| Cash And Equivalents | 347.87 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 253.11 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.32 X | ||||
| Book Value Per Share | 2.94 X | ||||
| Cash Flow From Operations | 58.2 M | ||||
| Earnings Per Share | (4.41) X | ||||
| Market Capitalization | 431.51 M | ||||
| Total Asset | 1.09 B | ||||
| Retained Earnings | (640.57 M) | ||||
| Working Capital | 209.01 M | ||||
About Definitive Healthcare Performance
By evaluating Definitive Healthcare's fundamental ratios, stakeholders can gain valuable insights into Definitive Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Definitive Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Definitive Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 80.05 | 61.86 | |
| Return On Tangible Assets | (1.04) | (0.99) | |
| Return On Capital Employed | (0.77) | (0.73) | |
| Return On Assets | (0.38) | (0.36) | |
| Return On Equity | (0.93) | (0.88) |
Things to note about Definitive Healthcare performance evaluation
Checking the ongoing alerts about Definitive Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Definitive Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Definitive Healthcare appears to be risky and price may revert if volatility continues | |
| Definitive Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 206.82 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: What drives Definitive Healthcare Corp. stock price - Free Stock Index Interpretation - Jammu Links News |
- Analyzing Definitive Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Definitive Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Definitive Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Definitive Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Definitive Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Definitive Healthcare's stock. These opinions can provide insight into Definitive Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Definitive Stock analysis
When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |